Adults with ADHD often struggle with choices that carry negative consequences. A new experiment reveals that stimulant ...
The FDA has given Motivista, a prescription digital therapeutic for adults with negative symptoms of schizophrenia, 510(k) ...
Are you stuck asking, “Why did this happen?” Here are eight steps to stop ruminating and get back to living life.
Positivity can be helpful, but forcing yourself to feel good during a difficult moment can make you ignore emotions that need ...
A weak September did not erase the gains built up by several SIF strategies over the previous six months. While the latest ...
Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer
Alliance Foundation Trials, LLC (AFT), a national leader in conducting innovative, practice-changing cancer clinical trials, ...
Key Points of This Article Article 50, Paragraph 10 of the Immigration Control Act stipulates that when a disposition of ...
Click Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (marketing authorization) for Motivista, a prescription digital therapeutic (PDT ...
Charting A Path Forward For Medicare Advantage: Expert Consensus On Policy Priorities And Trade-Offs
More than half of Medicare beneficiaries are enrolled in Medicare Advantage (MA), yet concerns persist about overpayments to MA plans, inadequate plan oversight, and limits on beneficiaries’ access to ...
For several decades, Norwegian prison research has focused on the pains of imprisonment, isolation and the harm that prison ...
Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia – a digital ...
Breast cancer treatment 2026 is increasingly personalized through targeted therapy, ADCs, genomics and immunotherapy while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results